In summary, considering an increase in TrkA and TrkC expression is associated with favorable biological features in neuroblastoma [6,7], RUNX3 may simply be categorized as a functional tumor suppressor in neuroblastoma because of its potential to positively regulate TrkA and TrkC. The gene discussed is NTRK3; the disease is neoplasm.